Lyfegen Nets $8 Million in Funding Deal to Support Value-Based Healthcare
The healthtech company Lyfegen has received $8 million in a Series A financing round to support its value-based pricing platform. With the cost of new biologics rising and the industry pivoting to value-based pricing, payer organizations need solutions to negotiate reimbursement. Lyfegen’s platform consolidates the process from start to finish. The funding will help the company expand these offerings for clients.
[Webinar] How Health Care Innovation Affects Life Expectancy and Patient Well-Being
The American Journal of Managed Care® recently hosted a webinar entitled "Bang for the Buck: How Health Care Innovation Affects [...]
Bringing Value-Based Insurance Design to Oncology
Although the oncology field has been increasingly adopting value-based insurance designs, much work yet remains. For decades, the traditional dogma [...]
Can Economic Evaluation Achieve Meaningful Use in Reducing Healthcare Costs in the US?
Despite being the most inefficient in terms of healthcare spending among developed nations, the United States does not routinely apply [...]
Market Expertz Releases New Report: Global Value-Based Reimbursement Software Market Report.
New report published by Market Expertz provides detailed overview of vital market components that aid in assessing current and future [...]
